Congruously, abdominal cavity injection of AGS cells with different HAS1 or HMMR expression also demonstrated HA was requisite for HMMR-mediated peritoneal implantation of gastric cancer (Fig. 4D). The gene discussed is HAS1; the disease is gastric cancer.